Skip to main content

Advertisement

Table 2 Overall toxicity from chemotherapy in selected cohort.

From: Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

Variable Category Number (%)
   N = 664
Anaemia stage 0 116 (17.5)
  1 241 (36.3)
  2 259 (39.0)
  3 39 (5.9)
  4 9 (1.4)
Leucopenia stage 0 171 (25.8)
  1 70 (10.5)
  2 96 (14.5)
  3 154 (23.2)
  4 173 (26.1)
Thrombocytopenia 0 503 (75.8)
  1 51 (7.7)
  2 45 (6.8)
  3 33 (5.0)
  4 32 (4.8)
Mucositis 0 347 (52.3)
  1 137 (20.6)
  2 98 (14.8)
  3 17 (2.6)
  4 3 (0.5)
  No data 62 (9.3)
Nausea/vomiting 0 329 (49.5)
  1 168 (25.3)
  2 68 (10.2)
  3 39 (5.9)
  4 5 (0.8)
  No data 55 (8.3)
Diarrhoea 0 434 (65.4)
  1 74 (11.1)
  2 50 (7.5)
  3 45 (6.8)
  4 7 (1.1)
  No data 54 (8.1)
Neuropathy 0 318 (47.9)
  1 192 (28.9)
  2 77 (11.6)
  3 26 (3.9)
  4 0
  No data 51 (7.7)
Skin rash 0 521 (78.5)
  1 50 (7.5)
  2 27 (4.1)
  3 7 (1.1)
  4 2 (0.3)
  No data 57 (8.6)